Merck, on Behalf of Its Wholly Owned Subsidiary Cubist Pharmaceuticals, Announces Results of Tender Offer for Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 and 1.875% Convertible Senior Notes Due 2020

Dateline City:

KENILWORTH, N.J.

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, on
behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc.,
today announced the results of its tender offer (the “Convertible
Notes Tender Offer”) pursuant to which each holder of Cubist’s
2.50% Convertible Senior Notes due 2017 (the “2017
Convertible Notes”), 1.125% Convertible Senior Notes due 2018
(the “2018 Convertible Notes”) and 1.875%
Convertible Senior Notes due 2020 (the “2020
Convertible Notes” and together with th
Language:

English

Contact:

MerckMedia:Lainie Keller, [phone]Steve Cragle, [phone]orInvestor:Joe Romanelli, [phone]Justin Holko, [phone]

Ticker Slug:

Ticker: MRK Exchange: NYSE

read more

Source: Merck.com - Corporate News - February 23, 2015 Category: Pharmaceuticals Tags: Corporate News Financial News Latest News Source Type: news